Dewi Shri Farmindo Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Dewi Shri Farmindo Tbk. trades at Rp139 (market cap 280B, 63.3M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Prodia Diagnostic Line Tbk is the larger of the two by market cap, and Dewi Shri Farmindo Tbk. is more actively traded (63.3M versus 28.43M). Which is the better fit depends on your goals.
| DEWI | PRDL | |
|---|---|---|
Market Cap | 280B | 470.58B |
Volume | 63.3M | 28.43M |
Lot | 632.99K | 284.34K |
Turnover | 8.85B | 7.8B |
Average Price | 139.84 | 274.19 |
Value | 8.85B | 7.8B |
Indicative Equilibrium Price | 139 | 270 |
Indicative Equilibrium Volume | 11.34K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Dewi Shri Farmindo Tbk (The "Company") is domiciled in Cianjur was established based on notarial deed No. 15 dated September 17, 2019 of Amaliyah, S.H.,M.Kn notary in Jakarta. The Company commenced commercial operations in 2019.
Read more on DEWI →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →